Liao, B., & Yang, J. C. (2012). Front-line erlotinib in unselected patient with advanced NSCLC followed by standard chemotherapy with gemcitabine and cisplatin - TORCH study. Transl Lung Cancer Res.
Stile di citazione ChicagoLiao, Bin-Chi, e James Chih-Hsin Yang. "Front-line Erlotinib in Unselected Patient With Advanced NSCLC Followed By Standard Chemotherapy With Gemcitabine and Cisplatin - TORCH Study." Transl Lung Cancer Res 2012.
Citazione MLALiao, Bin-Chi, e James Chih-Hsin Yang. "Front-line Erlotinib in Unselected Patient With Advanced NSCLC Followed By Standard Chemotherapy With Gemcitabine and Cisplatin - TORCH Study." Transl Lung Cancer Res 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.